Key result
Higher 72-hour ΔVTI–VeXUS is linked to ~21% lower odds of in-hospital mortality per unit in ADHF.
Why the study?
The ability of the VTI–VeXUS index to reflect treatment response and whether its early dynamic changes are associated with in-hospital mortality in acute decompensated heart failure (ADHF) were unknown.
Does early improvement in the VTI–VeXUS index over 72 hours predict reduced in-hospital mortality in patients hospitalized for acute decompensated heart failure?
Cohort (n=114)
Does early improvement in the VTI–VeXUS index over 72 hours predict reduced in-hospital mortality in patients hospitalized for acute decompensated heart failure?
Early improvement in the echocardiographic VTI–VeXUS index over the first 72 hours independently predicts lower in-hospital mortality in patients with acute decompensated heart failure, offering a potential bedside target to guide decongestion.
Answers are grounded in this paper and cite their sources.
ΔVTI–VeXUS improvement was associated with lower ADHF mortality; hypothesis-generating and requires prospective validation before clinical adoption.
Background The VTI–VeXUS index integrates arterial flow (LVOT-VTI) and venous congestion (VeXUS score) into a single haemodynamic metric. While proof-of-concept data in septic shock suggest potential prognostic value, its ability to reflect treatment response in acute decompensated heart failure (ADHF) is unknown. Purpose To evaluate whether early dynamic changes in the VTI–VeXUS index are associated with in-hospital mortality in patients admitted with ADHF. Methods We analysed a prospective cohort of patients hospitalized for ADHF who underwent echocardiographic assessment of LVOT-VTI and VeXUS at admission and after 72 hours. The VTI–VeXUS index was calculated as VTI/(VeXUS+1). Dynamic change (ΔVTI–VeXUS) was analysed as a continuous variable and in multivariable logistic regression adjusting for clinical severity markers. The primary outcome was in-hospital mortality. Results Among 114 patients, survivors demonstrated greater improvement in VTI–VeXUS over 72 hours compared with non-survivors. Each unit increase in ΔVTI–VeXUS was associated with a 25% reduction in the odds of in-hospital mortality (OR 0.75, 95% CI 0.60–0.90, p<0.05) and remained independently predictive after adjustment (OR 0.79, 95% CI 0.63–0.94, p=0.01). ROC analysis showed moderate discrimination (AUC≈0.71) for in-hospital mortality, and predicted mortality declined progressively with increasing ΔVTI–VeXUS. Conclusions In ADHF, early trajectory of the VTI–VExUS index identifies effective haemodynamic response and independently predicts survival. Serial assessment may provide an objective bedside target to guide decongestion therapy.
No takes yet. Share an insight, caveat, or question.
Saadi et al. (2026) conducted a cohort in Acute decompensated heart failure (ADHF) (n=114). 72-hour change in VTI–VeXUS index (ΔVTI–VeXUS) was evaluated on In-hospital mortality (OR 0.79, 95% CI 0.63-0.94, p=0.01). Each unit increase in 72-hour ΔVTI–VeXUS independently predicted lower odds of in-hospital mortality in ADHF (adjusted OR 0.79; 95% CI 0.63–0.94; p=0.01).
Synapse has enriched 10 related papers. Consider them for comparative context: